EUVIMEDEUVIMED entdecken
Open Access

Mechanistic Insights Into the Anti‐Constipation Potential of Xiaogan Jianwei Formula: Integration of HPLC‐Q‐TOF MS/MS, Network Pharmacology, In Vivo Validation, and Gut Microbiota

Tao Li iD, Yuting Wang, Bin Du, Jiale Mao, Shuang Liu, Songquan Wu, Qiaoyong Ye, Na Lin, Shaochang Wu, Houxing Lei, Xiaoqin Zhang iD

Biomedical Chromatography · 2026-09 · 40 (9)

DOI: 10.1002/bmc.70567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 23.07.2026. Verfasst von Tao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Lishui, Zhejiang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Gastrointestinal Microbiome, Constipation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Projects of Zhejiang Provincial Administration of Traditional Chinese Medicine, Scientific Research Project of the Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Zhejiang Chinese Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to explore the mechanism of action and potential bioactive constituents of Xiaogan Jianwei Formula (XG) in the treatment of constipation. The chemical constituents of XG and its absorbable components were characterized using HPLC‐Q‐TOF MS/MS, and network pharmacology was used to predict key targets and pathways, identifying the cAMP/PKA signaling pathway as a target pathway. In vivo experiments were performed to evaluate anti‐constipation effects, including measurements of fecal water content, intestinal transit rate, MUC2 expression, cAMP/PKA/AQP3 signaling, and gut microbiota composition via 16S rRNA sequencing. In total, 138 chemical constituents were identified from XG, of which 32 components were absorbable; flavonoids were the main active ingredients. Pharmacological studies showed that XG significantly increased fecal water content and intestinal transit rate in loperamide‐induced constipated rats without affecting physiological parameters. XG upregulated the expression of cAMP, PKA, p‐PKA, and AQP3 and restored MUC2 expression. Moreover, XG improved gut microbiota diversity, enriched beneficial bacteria such as Akkermansia , and reduced pathogenic taxa like Helicobacter and Campylobacterota. XG alleviates constipation by regulating the cAMP/PKA/AQP3 signaling axis and modulating the gut microbiota. This study provides a scientific basis for the clinical application of XG and supports its development as an effective medicine for constipation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalGastrointestinal MicrobiomeConstipationAnimalsChromatography, High Pressure LiquidTandem Mass SpectrometryNetwork PharmacologyRatsRats, Sprague-DawleyMaleSignal TransductionFeces

Stichwörter der Autor:innen

Xiaogan Jianwei FormulacAMP/PKA/AQP3 signaling axisconstipationflavonoidsgut microbiotagut mucus barrier

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Lishui, Zhejiang, China.
  • School of Medicine, Lishui University, Lishui, Zhejiang, China.
  • Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
  • Key Laboratory for Inheritance, Innovation and Development of She Ethnomedicine, Zhejiang, China.

ORCID-Profile: Tao Li, Xiaoqin Zhang

Förderung

  • Projects of Zhejiang Provincial Administration of Traditional Chinese Medicine
  • Scientific Research Project of the Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
  • Zhejiang Chinese Medical University

Zitieren

APA

Li, T., Wang, Y., Du, B., Mao, J., Liu, S., Wu, S., Ye, Q., Lin, N., Wu, S., Lei, H., & Zhang, X. (2026). Mechanistic Insights Into the Anti‐Constipation Potential of Xiaogan Jianwei Formula: Integration of HPLC‐Q‐TOF MS/MS, Network Pharmacology, In Vivo Validation, and Gut Microbiota. Biomedical Chromatography, 40(9). https://doi.org/10.1002/bmc.70567

Vancouver

Li T, Wang Y, Du B, Mao J, Liu S, Wu S, et al. Mechanistic Insights Into the Anti‐Constipation Potential of Xiaogan Jianwei Formula: Integration of HPLC‐Q‐TOF MS/MS, Network Pharmacology, In Vivo Validation, and Gut Microbiota. Biomedical Chromatography. 2026;40(9). doi:10.1002/bmc.70567

BibTeX
@article{Li2026,
  author = {Li, Tao and Wang, Yuting and Du, Bin and Mao, Jiale and Liu, Shuang and Wu, Songquan and Ye, Qiaoyong and Lin, Na and Wu, Shaochang and Lei, Houxing and Zhang, Xiaoqin},
  title = {Mechanistic Insights Into the Anti‐Constipation Potential of Xiaogan Jianwei Formula: Integration of HPLC‐Q‐TOF MS/MS, Network Pharmacology, In Vivo Validation, and Gut Microbiota},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {9},
  doi = {10.1002/bmc.70567}
}
Kostenlos starten →